Medical writers for office of tissues and advanced therapies (otat)
Ended Awarded Last action
- Contract number
- 75F40122F19002
- Awardee
-
Kaiva Strategies, LLC UEI HCWKVFGBPA64
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $839,700
Award facts
- Contract value 100% obligated
- $839,699.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Not Available for Competition Only One Source
- Pricing
- Labor Hours
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$813 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $840,513 |
About this award
This is a $839,699.93 delivery order contract awarded by the Food and Drug Administration (FDA) to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business. The contract is for medical writer support services for the FDA's Office of Tissues and Advanced Therapies (OTAT) and has a period of performance through September 30, 2023. Kaiva Strategies holds several small business certifications, including 8(a), HUBZone, and small disadvantaged business status, which have enabled the company to secure numerous prime contracts with the FDA and other agencies. This award is not associated with a set-aside program. Kaiva Strategies has provided a wide range of professional services to the FDA, including medical writing, scientific writing, and regulatory science communication support, across multiple FDA offices and centers. The company holds two significant Indefinite Delivery Contracts (IDCs) with the FDA, totaling $122 million, under which it has received multiple delivery orders to provide specialized expertise in support of the agency's public health missions.
Quick answers
Who was awarded contract 75F40122F19002?
75F40122F19002 was awarded to Kaiva Strategies, LLC by Food and Drug Administration (Department of Health and Human Services) on July 1, 2022.
How much is contract 75F40122F19002 worth?
The government has obligated $839,700 on 75F40122F19002.
Is contract 75F40122F19002 an order under another contract?
Yes. 75F40122F19002 is a delivery order under 75F40122D00018, an indefinite delivery contract.
Was contract 75F40122F19002 competed?
The extent of competition for 75F40122F19002 was not available for competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award